Current Trials

INTERACT3
INTERACT3

INTEnsive care bundle with blood pressure Reduction in Acute Cerebral haemorrhage Trial Lead PI:  Prof. Craig Anderson Status: Recruiting No. of…

MAEStro

A Randomized, Double-Blind, Placebo-Controlled,Dose-Response Efficacy and Safety Study of MLC1501 in Patients with Stroke   Lead PI: A/Prof Christopher CHEN…

MASTERS-2
MASTERS-2

MultiStem Administration for Stroke Treatment and Enhanced Recovery Study Lead PI: N/A Status: Site Selection No. of Patients Currently Recruited: 0                               No. of Patients…

MIDAS 2

Modafinil In Debilitating Fatigue After Stroke 2 Lead PI: Prof Chris Levi and Dr Andrew Bivard Status:  Recruiting  No. of…

Screen Shot 2023-01-04 at 9.40.16 am
OCEANIC STROKE

A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor…

OPTIMISTmain
OPTIMISTmain

Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …

PESTO

 A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality…

POST-ETERNAL Logo
POST-ETERNAL

Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation stroke Lead PI:  Dr Fana Alemseged Participating…

Screen Shot 2023-04-12 at 1.24.16 pm
QASC Australia

QUALITY IN ACUTE STROKE CARE (QASC) AUSTRALIA TRIAL Principal Investigator: Prof Sandy Middleton The Quality in Acute Stroke Care (QASC)…

1 2 3 4